Navigation Links
Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
Date:3/8/2011

RALEIGH, N.C., March 8, 2011 /PRNewswire/ -- Pioneer Surgical Technology today announces the market launch of their new portfolio of biologic products, designed to be used in extremities and pelvis.

The new portfolio will be showcased during the 2011 American College of Foot and Ankle Surgeons (ACFAS) convention in Fort Lauderdale this week. Pioneer Surgical Technology’s newest Biologics product, Legato™, will be included. Legato is a resorbable, collagen-based implant that acts as a scaffold for the in-growth of new bone and is designed to have broad appeal in repairing bony defects in the extremities and pelvis, including those caused by trauma. In addition, Legato forms a cohesive and adhesive product easily shaped to defects while maximizing direct contact with host bone.

Regarding Pioneer’s latest product introduction Mr. Shane Ray, General Manager – Biologics for Pioneer stated, “We are very pleased to expand our product offerings with Legato into the extremities, trauma and general othopaedics market. Our goal has always been to establish highly effective products first in spine and now expanding into additional high growth markets such as extremities. We saw incredible sales growth in 2010 and are executing our 2011 growth plans to expand our product offerings within and outside the United States.”

For more information regarding Pioneer’s Biologics Foot and Ankle offerings including Legato, please visit the Pioneer Surgical website at www.pioneersurgical.com.

About Pioneer Surgical Technology, Inc.

Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer’s focus on innovation has resulted in over 120 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopaedic, spine and biologic systems. Pioneer entered the orthobiologics market w
'/>"/>

SOURCE Pioneer Surgical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
3. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
4. New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
5. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
6. CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
7. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
8. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
9. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
10. Starch Medical Launches New, Bioinert Surgical Hemostats
11. Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)...  The Diabetes Research Institute (DRI), a Center ... School of Medicine, announced today that the first ... the first time a novel transplant technique for ... Phase I/II study builds upon decades of progress ... first step toward the development of the DRI ...
(Date:8/26/2015)... -- Intrexon Corporation (NYSE: XON ), a leader ... previously announced public offering of common stock, including the ... to purchase an additional 731,707 shares of common stock ...  The exercise of the underwriters, option brought the total ... to 5,609,756 shares and increased the total gross proceeds ...
(Date:8/26/2015)... HONG KONG , Aug. 26, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... Holdings Limited ("MO2"), an entity wholly owned by Mr. ... the Company, has acquired the outstanding shares (the "Shares") ...
(Date:8/26/2015)... CORAL SPRINGS, Florida , August 26, 2015 ... one of the biggest factors fueling the optimism ... FDA approvals, M&A,s, collaborations and life sciences advancements.  ... and developments are Pressure BioSciences, Inc. (OTCQB: PBIO), ... Inc. (NASDAQ: SRPT ), Raptor Pharmaceutical Corp. ...
Breaking Biology Technology:Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... Westerners Return from Beijing,s World-Class Stem Cell Treatment ... with Clear Improvement, Giving Hope Not Found ... Puhua Neurosurgical,Hospital, the world,s leading center for effective ... today here announced that four more,international patients returned ...
... Strategic Focus on Growth-Driving Global Products, BASINGSTOKE, ... SHPGY, TSX: SHQ), the global specialty biopharmaceutical,company, announces ... of non core,products to Almirall for a cash ... SOLARAZE(R) (3% gel diclofenac sodium),and VANIQA(R) (eflornithine hydrochloride), ...
... more about the origins of quantum dot blinking, ... National Laboratory, the University of Chicago and the ... to characterize it on faster time scales than ... material, also known as quantum dots, are being ...
Cached Biology Technology:American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot 2American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot 3American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot 4Shire Divests Non-Core Product Portfolio to Almirall 2Shire Divests Non-Core Product Portfolio to Almirall 3Argonne researcher studies what makes quantum dots blink 2
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that four of its fingerprint ... have officially been named FIDO Certified™ by the ... the certification, Synaptics, Natural ID™ fingerprint solutions are ... Framework (UAF) standard and are interoperable among other ...
(Date:8/6/2015)... and TELTOW, Germany , August 6, ... Conference, SensoMotoric Instruments (SMI) shows the world,s ... , based on Epson,s Moverio BT-200 see-through head ... With this new solution, unprecedented quality and efficiency is ... with context-sensitive displays. For the first time, professionals and ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... A new minute freshwater snail species belonging to the genus ... Athens (Canella Radea) in a spring covered by snow on ... access journal Zookeys . The ... shell, grey-black pigmented soft body and a black penis with a ...
... scientists may lead to a pharmaceutical breakthrough for a ... cells that line the inner surfaces of our body,s ... the FASEB Journal ( http://www.fasebj.org ), the ... small-molecule drug candidates which help cells bypass defective channels ...
... how humans develop immunity to malaria, and could ... Dr Alyssa Barry from the Walter and ... using ,protein microarray, technology to screen human blood ... the malaria-causing Plasmodium falciparum parasite. Her research, which ...
Cached Biology News:Scientists discover new drug candidates for cystic fibrosis and other diseases 2'Protein microarrays' may reveal new weapons against malaria 2
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Ubiquitin-like protein 4A (Ubiquitin-like protein GDX). [Source:Uniprot/SWISSPROT;Acc:P11441] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: